Cory H. - Chief Scientific Officer at Lung Therapeutics

Description

Cory H. has a long and distinguished career in medicine. In 2021, they began working as the Chief Scientific Officer for Lung Therapeutics, Inc.

Mining Patient Records to Help Crack the Code of COVID-19

Vertex's big move beyond cystic fibrosis hits a wall with lung

Tribune Pulse - July 29 - Volume VI - Issue 30

Drug-Induced Pulmonary Toxicity: Practice Essentials, Background

NIH Grants Conference

Bridging Specialties™: Timely Diagnosis for I

Compassionomics: The Revolutionary Scientific Evidence That

Articles about Lung Therapeutics

Genentech: Bob Yauch Executive Director, Discovery Oncology

Charlie Cory-Wright KC

$ 20.99USD
Score 4.6(110)
In stock
Continue to book